🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Day 1 recap 🔎 Miguel Hernán opened Key Topics in Causal Inference (KTCI) with an overview of #causlinference methodology & standardization. Judith Lok focused on conditioning and Inverse Probability Weighting. #publichealth #epidemiology #causalab

Interesting snapshot of growth in clinical AI publications in China NEJM AI (TLDR rapid growth but lagging in the highest visibility journals) and in which institutions.

Review on next generation immunotherapies in NSCLC doi.org/10.1038/s41571… #LCSM d.planchard Aɴᴛᴏɴɪᴏ Pᴀssᴀʀᴏ Benjamin Besse Sanjay Popat Giannis Mountzios Fred R. Hirsch Suresh S. Ramalingam, MD, FASCO Christine Lovly, MD, PhD, FASCO Hossein Borghaei, DO Joshua Reuss Chul Kim Biagio Ricciuti, MD, PhD Aakash Desai, MD, MPH, FASCO Eric K. Singhi, MD

After a CDK4/6 Inhibitor: State of the Art in Hormone Receptor–Positive Metastatic Breast Cancer ascopubs.org/doi/pdf/10.120…

Review Article: “Reading and Interpreting Quality-of-Life Results in Cancer Trials” by Massimo Di Maio: eviden.cc/431mUhd #Oncology #CancerResearch

Great to see such progress, but we have a lot of work to do for patients with lung, oesphageal, liver and pancreatic cancers. Reflects the absolute importance of #ClinicalTrial in improving outcomes CancerTrialsIreland 🌈 Trinity St James's Cancer Institute Irish Research Radiation Oncology Group Irish Cancer Society

🚨📢🌟 CURB2 Ph3 Trial is activated by @NCICTEP_ClinRes (NCT06686771), built upon CURB Ph2 RCT The Lancet/Memorial Sloan Kettering Cancer Center. Appreciate the support of NRG Oncology/SWOG Cancer Research Network/@CCTG. Pls contact us for activation at your local site❗️ Princess Margaret Cancer Centre Laura Dawson Alex Louie MD, PhD Houda Bahig, MD PhD

Beautiful review on neoadjuvant immunotherapy across tumor types & how we can further refine delivery and develop biomarkers Nature Cancer. Congratulations to Drs. Gil Awada, Tina Cascone, Michiel van der Heijden Christian Blank MarleenKokLab Myriam Chalabi nature.com/articles/s4301…

Happy to share our latest #review on #neoadjuvantimmunotherapy: an extensive overview of current and emerging data in NSCLC, TNBC, GI + bladder cancers, melanoma and many more: written with close friends and KOLs published today in Nature Cancer MarleenKokLab doi.org/10.1038/s43018…

ESMO has updated it’s living guidelines for oncogene addicted NSCLC #LCSM doi.org/10.1016/j.anno… d.planchard Aɴᴛᴏɴɪᴏ Pᴀssᴀʀᴏ Benjamin Besse Sanjay Popat Giannis Mountzios Fred R. Hirsch Suresh S. Ramalingam, MD, FASCO Christine Lovly, MD, PhD, FASCO Hossein Borghaei, DO Joshua Reuss Chul Kim Biagio Ricciuti, MD, PhD Aakash Desai, MD, MPH, FASCO

Prof. Alongi emphasizes how radiation oncology is poised to ride the AI revolution to an even brighter future for cancer care. A benefit for a specialty that delivers treatments with 1’s and 0’s. #radonc

Discontinuity negatively affects patients, learners, and health care systems. Changes that create continuity could improve both patient outcomes and the learning environment for medical trainees. Read the Review Article “Navigating the Discontinuity Crisis in Medical

hanging out with strangers in a campus pub should be considered part of the serious process of thinking

For dMMR colon cancer, FOLFOX + atezolizumab per ATOMIC is now incorporated into the NCCN Guidelines. Mayo Clinic Comprehensive Cancer Center Alliance for Clinical Trials in Oncology The ASCO Post Colorectal Cancer Alliance Cure GI Cancers Fight Colorectal Cancer

Viewpoint: Recognizing the heterogeneity of small cell lung cancer, efforts are underway to apply precision oncology through molecular subtyping and targeted therapies for tailored treatment. ja.ma/46eBXGi

After a brief hiatus, we are back w the teaching videos! Just recorded GI pathology 101 series w our awesome chief of GI pathology, Suntrea Hammer. Going to edit etc & share soon.

New review led by Deep Chakrabarti of The Royal Marsden NHS Foundation Trust outlines global trends and evolving diagnostics, treatment, and surveillance of #ProstateCancer. Read: acsjournals.onlinelibrary.wiley.com/doi/10.3322/ca… Chris Parker Amar Kishan Vedang Murthy Nicholas van As Alison Tree 💙 Advanced Prostate Cancer Consensus Conference The ICR

Real world adherence to biomarker recommended therapies JCO Oncology Practice. 1407 pts, 233 with actionable alteration on NGS - 86.3% received guideline recommended therapy (100% for EGFRdel19). Median 27d from diagnosis to NGS; 24d NGS to starting therapy. ascopubs.org/doi/10.1200/OP…

🏆 CtRO Young Researcher Award #ESTRO25 Why are locoregional recurrences higher after TNT in #rectalcancer? RAPIDO team found the risk rises only after sphincter-preserving surgery with ≤10mm distal margin likely due to TNT’s fragmented tumour response. 👉bit.ly/45PORdH

👉 ESMO Living Guidelines on Localised Rectal Cancer: New title in the library with all recommendations and algorithms from the published Guideline in an interactive format. #ESMOGuidelines 🔗 ow.ly/PggR50WkRKH erika martinelli